CAS 1799506-07-2

HaloPROTAC3

CAS: 1799506-07-2

HaloPROTAC3 (HaloPROTAC-3) is a conjugate of ligands for E3 and 16-atom-length linker and a degrader of HaloTag fusion proteins.

Formula: C₄₁H₅₅ClN₄O₈S

Purity: 95.44%

Color and Shape: Solid

Molecular weight: 799.42

Ref: TM-T32043

HaloPROTAC3

CAS: 1799506-07-2

HaloPROTAC3

Purity: ≥95%

Molecular weight: 799.42g/mol

Ref: 54-BUP01141

HaloPROTAC3

CAS: 1799506-07-2

HaloPROTAC3 is an inhibitor that targets kinases in human cancer cells. It has been shown to disrupt the cell cycle and induce apoptosis, making it a promising candidate for anticancer therapy. HaloPROTAC3 selectively targets specific proteins in cancer cells, resulting in the degradation of these proteins and inhibition of tumor growth. This inhibitor has been tested on various cell lines, including Chinese hamster ovary (CHO) cells and medicinal plants. Its potent anticancer activity makes it a promising candidate for further development as a cancer therapy. With its ability to selectively target kinases, HaloPROTAC3 holds great potential for the treatment of various types of cancer.

Formula: C₄₁H₅₅ClN₄O₈S

Purity: Min. 95%

Molecular weight: 799.4 g/mol

Ref: 3D-ZWC50607